BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32463435)

  • 1. Differences and Temporal Changes in Risk of Invasive Pneumococcal Disease in Adults with Hematological Malignancies: Results from a Nationwide 16-Year Cohort Study.
    Andersen MA; Niemann CU; Rostgaard K; Dalby T; Sørrig R; Weinberger DM; Hjalgrim H; Harboe ZB
    Clin Infect Dis; 2021 Feb; 72(3):463-471. PubMed ID: 32463435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pneumococcal disease among adults with hematological and solid organ malignancies: A population-based cohort study.
    Garcia Garrido HM; Knol MJ; Heijmans J; van Sorge NM; Sanders EAM; Klümpen HJ; Grobusch MP; Goorhuis A
    Int J Infect Dis; 2021 May; 106():237-245. PubMed ID: 33781907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
    Sadlier C; O'Connell S; Kelleher M; Bergin C
    Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality.
    Harboe ZB; Dalby T; Weinberger DM; Benfield T; Mølbak K; Slotved HC; Suppli CH; Konradsen HB; Valentiner-Branth P
    Clin Infect Dis; 2014 Oct; 59(8):1066-73. PubMed ID: 25034421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Hypogammaglobulinemia in Adult Invasive Pneumococcal Disease.
    Cowan J; Do TL; Desjardins S; Ramotar K; Corrales-Medina V; Cameron DW
    Clin Infect Dis; 2018 Feb; 66(4):564-569. PubMed ID: 29401274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of invasive pneumococcal disease in haematological and solid-organ malignancies.
    Wong A; Marrie TJ; Garg S; Kellner JD; Tyrrell GJ;
    Epidemiol Infect; 2010 Dec; 138(12):1804-10. PubMed ID: 20429967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Invasive Pneumococcal Disease in Cancer Patients After the Introduction of 7-valent Pneumococcal Conjugate Vaccine: A 20-year Longitudinal Study at a Major Urban Cancer Center.
    Lee YJ; Huang YT; Kim SJ; Kerpelev M; Gonzalez V; Kaltsas A; Papanicolaou G
    Clin Infect Dis; 2018 Jan; 66(2):244-253. PubMed ID: 29020313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs.
    Shigayeva A; Rudnick W; Green K; Chen DK; Demczuk W; Gold WL; Johnstone J; Kitai I; Krajden S; Lovinsky R; Muller M; Powis J; Rau N; Walmsley S; Tyrrell G; Bitnun A; McGeer A;
    Clin Infect Dis; 2016 Jan; 62(2):139-47. PubMed ID: 26354970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pneumococcal disease in patients with haematological malignancies before routine use of conjugate vaccines in Finland.
    Lindström V; Aittoniemi J; Lyytikäinen O; Klemets P; Ollgren J; Silvennoinen R; Nuorti JP; Sinisalo M
    Infect Dis (Lond); 2016; 48(5):399-402. PubMed ID: 26635103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
    Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
    Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the changing pneumococcal national immunisation program among older Australians.
    Menzies R; Stein AN; Booy R; Van Buynder PG; Litt J; Cripps AW
    Vaccine; 2021 Jan; 39(4):720-728. PubMed ID: 33384189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pneumococcal conjugate vaccines on the incidence of invasive pneumococcal disease caused by ten non-vaccine serotypes in Denmark.
    Slotved HC; Dalby T; Hoffmann S
    Vaccine; 2016 Feb; 34(6):769-74. PubMed ID: 26772630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.
    Weatherholtz R; Millar EV; Moulton LH; Reid R; Rudolph K; Santosham M; O'Brien KL
    Clin Infect Dis; 2010 May; 50(9):1238-46. PubMed ID: 20367225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease in Northern Alberta, not a Red Queen but a dark horse.
    Marrie TJ; Tyrrell GJ; Majumdar SR; Eurich DT
    Vaccine; 2018 May; 36(21):2985-2990. PubMed ID: 29685595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the screening and indirect cohort methods to evaluate the effectiveness of pneumococcal vaccination program in adults 75 years and older in Taiwan.
    Su WJ; Chuang PH; Chang LY; Lo HY; Chiang CS; Wang ET; Yang CH
    BMC Infect Dis; 2021 Jan; 21(1):45. PubMed ID: 33423657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in children under 5 years of age in the Czech Republic.
    Kozakova J; Krizova P; Maly M
    PLoS One; 2021; 16(2):e0247862. PubMed ID: 33635933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.